Multiple analyses of clinicopathological features and molecular markers that predict HP dependence of gastric DLBCL using logistic regression analyses
| Characteristics . | Hazard ratio . | HP dependence . | P . |
|---|---|---|---|
| 95% CI . | |||
| Endoscopic features | |||
| Gastritis-like or multiple erosion vs ulcerated mass or nodular lesions | 1.595 | 0.323-7.870 | .566 |
| Location of tumors | |||
| Distal* vs proximal† or ≥2 components | 3.691 | 0.708-19.243 | .121 |
| Depth of gastric wall involvement | |||
| Submucosa or above vs muscularis propria or beyond | 3.832 | 0.864-16.983 | .077 |
| CagA expression | |||
| Positive vs negative | 8.425 | 2.167-32.753 | .002 |
| Characteristics . | Hazard ratio . | HP dependence . | P . |
|---|---|---|---|
| 95% CI . | |||
| Endoscopic features | |||
| Gastritis-like or multiple erosion vs ulcerated mass or nodular lesions | 1.595 | 0.323-7.870 | .566 |
| Location of tumors | |||
| Distal* vs proximal† or ≥2 components | 3.691 | 0.708-19.243 | .121 |
| Depth of gastric wall involvement | |||
| Submucosa or above vs muscularis propria or beyond | 3.832 | 0.864-16.983 | .077 |
| CagA expression | |||
| Positive vs negative | 8.425 | 2.167-32.753 | .002 |